Nirav Jhaveri's most recent trade in Opus Genetics Inc. was a trade of 52,500 Common Stock done . Disclosure was reported to the exchange on March 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc | Nirav Jhaveri | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 52,500 | 194,293 | - | 0 | Common Stock | |
| Opus Genetics Inc | Nirav Jhaveri | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 52,500 | 52,500 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc | Nirav Jhaveri | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 13 Feb 2025 | 8,207 | 141,793 | - | 1.1 | 9,438 | Common Stock |
| Opus Genetics Inc | Nirav Jhaveri | Chief Financial Officer | 21 Mar 2024 | 10,000 | 150,000 | - | 2.1 | 21,000 | Common Stock | |
| Opus Genetics Inc | Nirav Jhaveri | Chief Financial Officer | 12 Feb 2024 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | ||
| Opus Genetics Inc | Nirav Jhaveri | Chief Financial Officer | 12 Feb 2024 | 140,000 | 140,000 | - | 0 | Common Stock |